Abstract
Epilepsies are very diverse conditions with marked variations in aetiology, clinical presentation and treatment outcome. Over the past decade, the understanding of epilepsy has made tremendous strides with the discovery of new genes and advanced imaging techniques. This has led to the 2010 International League Against Epilepsy (ILAE) re-organization of the classification of seizures and epilepsy syndromes. This current classification guides the investigations, treatment of seizures and the associated comorbid conditions in children with epilepsy and continues to evolve. This chapter covers the current classification of seizures and epilepsy syndromes. The management of a child presenting with epilepsy poses many challenges particularly in resource-limited settings. The chapter highlights a standard approach to the “workup” for a child presenting with seizures, associated comorbid conditions and treatment recommendations based on the current evidence-based practice. Additionally, the chapter provides a description of the common epilepsy syndromes and indications for referral to a paediatric neurologist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO. World Health Organization. International Classification of Functioning Disability and Health: ICF. Geneva; 2001.
Leonardi M, Ustun TB. The global burden of epilepsy. Epilepsia. 2002;43(Suppl 6):21–5.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010;51:883–90.
Hauser WA. Epidemiology of epilepsy in children. Neurosurg Clin N Am. 1995;6:419–29.
Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37:19–23.
Wilmshurst JM, Berg AT, Lagae L, Newton CR, Cross JH. The challenges and innovations for therapy in children with epilepsy. Nat Rev Neurol. 2014;10:249–60.
Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet Lond Engl. 2012;380:1193–201.
Wilmshurst JM, Birbeck GL, Newton CR. Epilepsy is ubiquitous, but more devastating in the poorer regions of the world... or is it? Epilepsia. 2014;55:1322–5.
Flink R, et al. Guidelines for the use of EEG methodology in the diagnosis of epilepsy. International League Against Epilepsy: commission report. Commission on European Affairs: Subcommission on European Guidelines. Acta Neurol Scand. 2002;106:1–7.
Gaillard WD, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia. 2009;50:2147–53.
Hirtz D, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology. 2000;55:616–23.
Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics. 2000;105:e10.
Dhamija R, Patterson MC, Wirrell EC. Epilepsy in children—when should we think neurometabolic disease? J Child Neurol. 2012;27:663–71.
Dulac O, Plecko B, Gataullina S, Wolf NI. Occasional seizures, epilepsy, and inborn errors of metabolism. Lancet Neurol. 2014;13:727–39.
Scheffer IE. Epilepsy genetics revolutionizes clinical practice. Neuropediatrics. 2014;45:70–4.
Lemke JR, et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia. 2012;53:1387–98.
Ottman R, et al. Genetic testing in the epilepsies – report of the ILAE Genetics Commission. Epilepsia. 2010;51:655–70.
Clancy RR. Summary proceedings from the neurology group on neonatal seizures. Pediatrics. 2006;117:S23–7.
Holmes GL, Khazipov R, Ben-Ari Y. New concepts in neonatal seizures. Neuroreport. 2002;13:A3–8.
Glass HC, Sullivan JE. Neonatal seizures. Curr Treat Options Neurol. 2009;11:405–13.
Volpe JJ. Neonatal seizures: current concepts and revised classification. Pediatrics. 1989;84:422–8.
Korff C, Nordli DR. Do generalized tonic-clonic seizures in infancy exist? Neurology. 2005;65:1750–3.
Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res. 2007;73:245–9.
Panayiotopoulos CP. A clinical guide to epileptic syndromes and their treatment: Springer-Verlag; 2010.
Ohtahara S, Yamatogi Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006;70(Suppl 1):S58–67.
Chien Y-H, et al. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. J Child Neurol. 2004;19:39–42.
Wang PJ, et al. The controversy regarding diagnostic criteria for early myoclonic encephalopathy. Brain and Development. 1998;20:530–5.
Engel J, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796–803.
Cone TE. On a peculiar form of infantile convulsions (hypsarrhythmia) as described in his own infant son by Dr. W.J. West in 1841. Pediatrics. 1970;46:603.
Pellock JM, et al. Infantile spasms: a U. S. consensus report. Epilepsia. 2010;51:2175–89.
Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355–67.
Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:255–65.
Kothare SV, et al. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations. Epilepsia. 2014;55:1020–4.
Lux AL, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712–7.
Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain J Neurol. 2012;135:2329–36.
Sakauchi M, et al. Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia. 2011;52:1144–9.
Specchio N, et al. Electroencephalographic features in dravet syndrome: five-year follow-up study in 22 patients. J Child Neurol. 2012;27:439–44.
Kassaï B, et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia. 2008;49:343–8.
Chiron C, et al. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol. 2006;21:496–502.
Agostinelli S, et al. Clinical dissection of early onset absence epilepsy in children and prognostic implications. Epilepsia. 2013;54:1761–70.
Sadleir LG, Scheffer IE, Smith S, Connolly MB, Farrell K. Automatisms in absence seizures in children with idiopathic generalized epilepsy. Arch Neurol. 2009;66:729–34.
Matricardi S, Verrotti A, Chiarelli F, Cerminara C, Curatolo P. Current advances in childhood absence epilepsy. Pediatr Neurol. 2014;50:205–12.
Panayiotopoulos CP. The atlas of epilepsies: Springer; 2010.
Arzimanoglou A, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82–93.
Camfield PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia. 2011;52(Suppl 5):3–9.
Montouris GD, Wheless JW, Glauser TA. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia. 2014;55(Suppl 4):10–20.
Kossoff EHW, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55(Suppl 4):29–33.
Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood – definition, course, nosography, and genetics. Adv Neurol. 2005;95:147–55.
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52:988–93.
Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl. 1992;6:163–8.
Tsai M-H, et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia. 2013;54:280–7.
Sánchez Fernández I, et al. Continuous spikes and waves during sleep: Electroclinical presentation and suggestions for management. Epilepsy Res Treat. 2013;2013:583531.
Sánchez Fernández I, Loddenkemper T, Peters JM, Kothare SV. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol. 2012;47:390–410.
Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia. 1994;35:285–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kija, E., Wilmshurst, J.M. (2020). Approach to a Child with Epilepsy. In: Salih, M.A. (eds) Clinical Child Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-43153-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-43153-6_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43152-9
Online ISBN: 978-3-319-43153-6
eBook Packages: MedicineMedicine (R0)